Correlation Between GM and NovaBay Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GM and NovaBay Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and NovaBay Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and NovaBay Pharmaceuticals, you can compare the effects of market volatilities on GM and NovaBay Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of NovaBay Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and NovaBay Pharmaceuticals.
Diversification Opportunities for GM and NovaBay Pharmaceuticals
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between GM and NovaBay is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and NovaBay Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NovaBay Pharmaceuticals and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with NovaBay Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NovaBay Pharmaceuticals has no effect on the direction of GM i.e., GM and NovaBay Pharmaceuticals go up and down completely randomly.
Pair Corralation between GM and NovaBay Pharmaceuticals
Allowing for the 90-day total investment horizon General Motors is expected to generate 0.28 times more return on investment than NovaBay Pharmaceuticals. However, General Motors is 3.52 times less risky than NovaBay Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. NovaBay Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest 3,294 in General Motors on September 20, 2024 and sell it today you would earn a total of 1,740 from holding General Motors or generate 52.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
General Motors vs. NovaBay Pharmaceuticals
Performance |
Timeline |
General Motors |
NovaBay Pharmaceuticals |
GM and NovaBay Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GM and NovaBay Pharmaceuticals
The main advantage of trading using opposite GM and NovaBay Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, NovaBay Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBay Pharmaceuticals will offset losses from the drop in NovaBay Pharmaceuticals' long position.The idea behind General Motors and NovaBay Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.NovaBay Pharmaceuticals vs. Immix Biopharma | NovaBay Pharmaceuticals vs. Cns Pharmaceuticals | NovaBay Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | NovaBay Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |